Prevalence of XMRV Nucleic Acid and Antibody in HIV-1-Infected Men and in Men at Risk for HIV-1 Infection

Table 1

XMRV antibody reactivity for the MACS Subjects.

MACS ID	CMIA (S/CO)			WB
	p15E; TM	gp70; SU	p30*; CA
222	1.67	0.08	0.23	p15E+, p30+
217	0.22	28.48	0.17
229	0.18	8.73	0.19
215	0.17	21.36	0.21	gp70+
227	0.20	2.27	0.18	p30+
231	0.17	1.56	0.18
210	0.18	1.65	0.22
211	0.17	1.47	0.20
233	0.19	1.80	0.20
Control
NC	0.17	0.11	0.23
PC1	7.90	12.82	3.70	gp70+, p15E+, p30+
PC2	2.22	3.47	1.10	NA

*Samples were tested at 1 : 2.5–5 dilutions due to limited sample volume.